[New Onset of Graves' Orbitopathy Following Bendamustine-Rituximab (BR) therapy in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature Review]. [PDF]
Kozlov ED +3 more
europepmc +1 more source
[Management of Graves' orbitopathy. Comments on the EUGOGO consensus statement].
Tomasz, Bednarczuk +28 more
openaire +1 more source
The role of monoclonal antibodies against IL-6 or IL-6R in the treatment of thyroid eye disease. [PDF]
Ezra DG +7 more
europepmc +1 more source
Sarilumab in the management of Graves orbitopathy with low clinical activity scores. [PDF]
Pérez-Moreiras J +3 more
europepmc +1 more source
A Case Report of a Patient with Thyroid eye disease Induced by Hashimoto's Thyroiditis. [PDF]
Khaskhazyan MH +4 more
europepmc +1 more source
Editorial: Thyroid eye disease. [PDF]
Kahana A +4 more
europepmc +1 more source
Targeting IL-6 Receptor Signaling with Satralizumab in Thyroid Eye Disease: Design of the Phase 3 SatraGO-1 and SatraGO-2 Trials. [PDF]
Ezra D +7 more
europepmc +1 more source
Thyroid eye disease in paediatric Graves' disease: a case series from the Gulf region with comparison to adults. [PDF]
Aljufairi FMAA +14 more
europepmc +1 more source
Efficacy and safety of various Intravenous Methylprednisolone regimens in Moderate to Severe Thyroid Eye Disease: A systematic review. [PDF]
Aishwarya A +3 more
europepmc +1 more source
What has changed in thyroid eye disease in the last five years (2020-2025). [PDF]
Salvi M.
europepmc +1 more source

